Stock Price
265.60
Daily Change
2.10 0.80%
Monthly
14.90%
Yearly
-37.41%
Q2 Forecast
247.42

Novo Nordisk reported DKK118.94B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Bausch Health Companies USD 20.62B 152M Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Novo Nordisk DKK 118.94B 29.76B Dec/2025
Novo Nordisk DKK 14.02B 224.49M Sep/2025
Pacira USD 372.19M 4.53M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022